CN Patent

CN115569119A — 具有改善稳定性的阿拉莫林片剂的生产方法

Assigned to Helsinn Healthcare SA · Expires 2023-01-06 · 3y expired

What this patent protects

用于降低阿拉莫林盐酸盐的成品剂量形式中杂质形成的方法，其包括用于改善这种稳定性的制剂和用于控制杂质形成的分析技术。

USPTO Abstract

用于降低阿拉莫林盐酸盐的成品剂量形式中杂质形成的方法，其包括用于改善这种稳定性的制剂和用于控制杂质形成的分析技术。

Drugs covered by this patent

Patent Metadata

Patent number
CN115569119A
Jurisdiction
CN
Classification
—
Expires
2023-01-06
Drug substance claim
No
Drug product claim
No
Assignee
Helsinn Healthcare SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.